Project Name: Barts Breast Cancer Capacity Service Redesign

Project Summary:

The CWP aims to redesign and expand the breast cancer service with the addition of a Clinical Nurse Specialist (CNS) to streamline the oral chemotherapy pathway. This will address the staff shortages being experienced by the CW Partner and help tackle the backlog of patients. 

Specifically, via integrating the Breast Cancer CNS into the service, the CWP aims to: 

  • improve patient outcomes and experience by reducing time between referral, diagnosis, and treatment, 
  • increasing awareness of the cancer pathway and empowerment of their care; 
  • supporting the breast cancer team with management of patient databases 

Planned Milestones:

  • Kick-off meeting
  • employment of CNS by Barts; Implement in-patient strategies/protocols and procedures governing the clinical operations of the Breast Cancer Service. Begin clinical operations according to the developed protocols, monitor and collect data. 
  • Carry out 3 months of clinical operations according to the developed protocols, Barts to monitor and collect data, provide anonymised report containing such data to Novartis to assess against milestone 
  • Carry out 6 months of clinical operations according to the developed protocols, Barts to monitor and collect data, provide anonymised report containing such data to Novartis to assess against milestone 
  • Carry out 9 months of clinical operations according to the developed protocols, Barts to monitor and collect data, provide anonymised report containing such data to Novartis to assess against milestone 
  • Carry out 12 months of clinical operations according to the developed protocols, Barts to monitor and collect data, provide anonymised report containing such data to Novartis to assess against milestone 
  • Carry out 15 months of clinical operations according to the developed protocols, Barts to monitor and collect data, provide anonymised report containing such data to Novartis to assess against milestone 
  • Carry out 18 months of clinical operations according to the developed protocols, Barts to monitor and collect data, provide anonymised report containing such data to Novartis to assess against milestone 
  • Barts develop business case to supportfuture funding of the service 
  • Write up / Outcomes Summary
  • Wrap-up meeting

Expected Benefits:

Anticipated benefits for patients

  • Improved access to evidence-based treatment;   
  • more equitable and consistent care and access to care.   
  • enhanced experience for patients and their carers who live with Breast Cancer Diagnosis.  
  • Increased access to Education on Breast Cancer will enable patients to distinguish potential disease progression and the side effects of treatment. 
  • A personalised Breast cancer care plan will help the patient education and awareness

Anticipated benefits for the CW Partner

  • Increase the overall quality of care and improve equity of access to specialist care for patients with Breast Cancer;  
  • Reduction in waiting list times 
  • Increased awareness of the breast cancer treatment pathway

Anticipated Benefits for Novartis

  • Better understanding of overall customers’ and patients’ needs
  • Optimal use of medicines (including Novartis medicines) in appropriate patients.

Start Date & Duration: April 2023 for 24 months

UK2304279878